documents
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
12 rows where docket_id = "FDA-2022-N-1794" sorted by posted_date descending
This data as json, CSV (advanced)
Suggested facets: subtype, posted_date, posted_month, comment_start_date, last_modified, open_for_comment, posted_date (date), comment_start_date (date), comment_end_date (date), last_modified (date)
| id | agency_id | docket_id | title | document_type | subtype | posted_date ▲ | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2022-N-1794-0012 | FDA | None FDA-2022-N-1794 | Agency Information Collection Activities; Announcement of Office of Management and Budget Approvals | Notice | Notice of Publication | 2023-05-04T04:00:00Z | 2023 | 5 | 2023-05-04T04:00:00Z | 2023-05-04T13:47:14Z | 2023-09401 | 0 | 0 | 09000064859ca728 | |
| FDA-2022-N-1794-0011 | FDA | None FDA-2022-N-1794 | Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; General Drug Labeling Provisions and Over-the-Counter Monograph Drug User Fee Submissions | Notice | 30 Day Proposed Information Collection | 2022-12-13T05:00:00Z | 2022 | 12 | 2022-12-13T05:00:00Z | 2023-01-13T04:59:59Z | 2022-12-13T16:35:12Z | 2022-27016 | 0 | 0 | 0900006485532493 |
| FDA-2022-N-1794-0007 | FDA | None FDA-2022-N-1794 | Providing Over-the-Counter Monograph Submissions in Electronic Format Guidance for Industry Draft Guidance | Other | Guidance | 2022-11-25T05:00:00Z | 2022 | 11 | 2022-11-25T05:00:00Z | 2024-11-07T00:43:46Z | 1 | 0 | 0900006485500a9c | ||
| FDA-2022-N-1794-0005 | FDA | None FDA-2022-N-1794 | Nonprescription Sunscreen Drug Products Format and Content of Data Submissions Guidance for Industry | Other | Guidance | 2022-11-25T05:00:00Z | 2022 | 11 | 2022-11-25T05:00:00Z | 2022-11-25T18:11:15Z | 0 | 0 | 0900006485500d2b | ||
| FDA-2022-N-1794-0002 | FDA | None FDA-2022-N-1794 | Quantitative Labeling of Sodium, Potassium, and Phosphorus for Human Over the Counter and Prescription Drug Products; Guidance for Industry Draft Guidance | Other | Guidance | 2022-11-25T05:00:00Z | 2022 | 11 | 2022-11-25T05:00:00Z | 2024-11-07T00:44:01Z | 1 | 0 | 0900006485500493 | ||
| FDA-2022-N-1794-0008 | FDA | None FDA-2022-N-1794 | Assessing User Fees Under the Over-the-Counter Monograph Drug User Fee Program Guidance for Industry Draft Guidance | Other | Guidance | 2022-11-25T05:00:00Z | 2022 | 11 | 2022-11-25T05:00:00Z | 2024-11-07T00:43:58Z | 1 | 0 | 0900006485500da3 | ||
| FDA-2022-N-1794-0009 | FDA | None FDA-2022-N-1794 | Quantitative Labeling of Sodium, Potassium, and Phosphorus for Human Over the Counter and Prescription Drug Products Guidance for Industry; Draft Guidance | Other | Guidance | 2022-11-25T05:00:00Z | 2022 | 11 | 2022-11-25T05:00:00Z | 2024-11-07T00:43:46Z | 1 | 0 | 0900006485500ab5 | ||
| FDA-2022-N-1794-0003 | FDA | None FDA-2022-N-1794 | Guidance for Industry Labeling of Nonprescription Human Drug Products Marketed Without an Approved Application as Required by the Dietary Supplement and Nonprescription Drug Consumer Protection Act: Questions and Answers | Other | Guidance | 2022-11-25T05:00:00Z | 2022 | 11 | 2022-11-25T05:00:00Z | 2024-11-07T00:44:01Z | 1 | 0 | 0900006485500495 | ||
| FDA-2022-N-1794-0006 | FDA | None FDA-2022-N-1794 | Nonprescription Sunscreen Drug Products— Safety and Effectiveness Data Guidance for Industry | Other | Guidance | 2022-11-25T05:00:00Z | 2022 | 11 | 2022-11-25T05:00:00Z | 2025-02-18T02:00:37Z | 1 | 0 | 0900006485500a98 | ||
| FDA-2022-N-1794-0010 | FDA | None FDA-2022-N-1794 | Formal Meetings Between FDA and Sponsors or Requestors of Over-the-Counter Monograph Drugs Guidance for Industry Draft Guidance | Other | Guidance | 2022-11-25T05:00:00Z | 2022 | 11 | 2022-11-25T05:00:00Z | 2024-11-12T23:47:19Z | 1 | 0 | 0900006485500d34 | ||
| FDA-2022-N-1794-0004 | FDA | None FDA-2022-N-1794 | Statement of Identity and Strength — Content and Format of Labeling for Human Nonprescription Drug Products Guidance for Industry | Other | Guidance | 2022-11-25T05:00:00Z | 2022 | 11 | 2022-11-25T05:00:00Z | 2024-11-12T23:47:18Z | 1 | 0 | 0900006485500486 | ||
| FDA-2022-N-1794-0001 | FDA | None FDA-2022-N-1794 | Agency Information Collection Activities; Proposed Collection; Comment Request; General Drug Labeling Provisions and Over-the-Counter Monograph Drug User Fee Submissions | Notice | 60 Day Proposed Information Collection | 2022-09-09T04:00:00Z | 2022 | 9 | 2022-09-09T04:00:00Z | 2022-11-09T04:59:59Z | 2022-09-09T12:52:16Z | 2022-19502 | 0 | 0 | 09000064852d6bd2 |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE documents (
id TEXT PRIMARY KEY,
agency_id TEXT,
docket_id TEXT REFERENCES dockets(id),
title TEXT,
document_type TEXT,
subtype TEXT,
posted_date TEXT,
posted_year INTEGER,
posted_month INTEGER,
comment_start_date TEXT,
comment_end_date TEXT,
last_modified TEXT,
fr_doc_num TEXT,
open_for_comment INTEGER,
withdrawn INTEGER,
object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);
CREATE INDEX idx_docs_comment_end ON documents(comment_end_date) WHERE comment_end_date IS NOT NULL AND withdrawn = 0;